Neumora Therapeutics is trading 6.02% up at $0.58 after hours on October 1, 2026, reversing its regular-session decline, with no new company-specific announcement or clear catalyst identified.
- The investor-relations page lists its latest release as August 14, 2026, reporting second-quarter results and a business update.
- The next listed release is dated July 27.
- The broader market finished modestly higher, but supplied index moves were below 0.5%, so they do not establish a market-driven explanation.